JC-171 (JC171)

JC-171 (JC171) Suppliers list
Company Name: Shanghai YuanYe Biotechnology Co., Ltd.  
Tel: 15026964105
Email: 2881489226@qq.com
Company Name: ChemeGen(Shanghai) Biotechnology Co.,Ltd.  
Tel: 18818260767
Email: sales@chemegen.com
Company Name: Beijing Jin Ming Biotechnology Co., Ltd.  
Tel: 010-60605840
Email: psaitong@jm-bio.com
Company Name: TargetMol Chemicals Inc.  
Tel: 4008200310 15002144251
Email: marketing@tsbiochem.com
Company Name: Shanghai Yifei Biotechnology Co. , Ltd.  
Tel: 021-65675885 18964387627
Email: customer_service@efebio.com

JC-171 (JC171) manufacturers

  • JC-171
  • JC-171 pictures
  • $297.00
  • 2026-04-22
  • CAS:2112809-98-8
  • Purity:
  • Supply Ability: 10g
JC-171 (JC171) Basic information
Product Name:JC-171 (JC171)
Synonyms:JC-171 (JC171);Benzamide, 5-chloro-N-[2-[4-[(hydroxyamino)sulfonyl]phenyl]ethyl]-2-methoxy-
CAS:2112809-98-8
MF:C16H17ClN2O5S
MW:384.83
EINECS:
Product Categories:
Mol File:2112809-98-8.mol
JC-171

(JC171) Structure
JC-171 (JC171) Chemical Properties
density 1.401±0.06 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMSO: 250 mg/mL (649.64 mM)
form Solid
pka6.43±0.69(Predicted)
color White to off-white
Safety Information
MSDS Information
JC-171 (JC171) Usage And Synthesis
UsesJC-171 is a selective NLRP3 inflammasome inhibitor, with an IC50 of 8.45 μM for inhibiting LPS/ATP-induced interleukin-1β (IL-1β) release from J774A.1 macrophages[1].
in vivo

JC-171 treatment delays the progression and reduces the severity of experimental autoimmune encephalomyelitis (EAE) in mouse[1].

Animal Model:Mice immunized subcutaneously with 200 μg Myelin oligodendrocyte glycoprotein (MOG) 35–55 peptide emulsified in Complete Freund’s Adjuvant (CFA) on day 0 followed by injection of 200 ng of pertussis toxin.
Dosage:100 mg/kg, 10 mg/kg.
Administration:IP days 0, 1 and 2; and every other days thereafter (100 mg/kg).
Initiated when the clinical scores of individual mice have reached 1 (flaccid tail), and given every other day (10 mg/kg).
Result:Efficiently suppressed EAE progression compared with vehicle treatment.
Resulted in a substantial decrease in the frequency of MOG35–55-specific Th17 cells in the spleens and spinal cords of EAE mice.
IC 50NLRP3
References[1] Chunqing Guo, et al. Development and Characterization of a Hydroxyl-Sulfonamide Analogue, 5-Chloro-N-[2-(4-hydroxysulfamoyl-phenyl)-ethyl]-2-methoxy-benzamide, as a Novel NLRP3 Inflammasome Inhibitor for Potential Treatment of Multiple Sclerosis. ACS Chem Neurosci. 2017 Oct 18;8(10):2194-2201. DOI:10.1021/acschemneuro.7b00124
JC-171 (JC171) Preparation Products And Raw materials
Tag:JC-171 (JC171)(2112809-98-8) Related Product Information
1-Butyl-3-[[4-[2-[(5-chloro-2-Methoxybenzoyl)aMino]ethyl]phenyl] Sulfonyl Urea JC-171 (JC171) Benzamide, 5-chloro-2-methoxy-N-[2-[4-[(methylamino)sulfonyl]phenyl]ethyl]- 4-(2-(5-Chloro-2-methoxybenzamido)ethyl)benzenesulfamide RO 5126946 5-chloro-2-methoxy-N-methyl-3-sulfamoylbenzamide